<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nodgo</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал детской гематологии и онкологии (РЖДГиО)</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Pediatric Hematology and Oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-1267</issn><issn pub-type="epub">2413-5496</issn><publisher><publisher-name>LTD “Graphica”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21682/2311-1267-2020-7-3-54-63</article-id><article-id custom-type="elpub" pub-id-type="custom">nodgo-625</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Редкие коагулопатии</article-title><trans-title-group xml:lang="en"><trans-title>Rare bleeding disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4555-9337</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флоринский</surname><given-names>Д. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Florinskiy</surname><given-names>D. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дмитрий Борисович Флоринский, врач-ординатор</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Resident in Pediatrics</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">mitia94@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4384-6754</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жарков</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zharkov</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, врач-гематолог консультативного отделения, врач-педиатр стационара кратковременного лечения, руководитель группы исследования гемостаза</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Dr. of Sci. (Med.), Hematologist Advisory Unit, Short-Term Hospital Pediatrician, Head of the Hemostasis Research Group</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">pavel.zharkov@fccho-moscow.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>20</day><month>09</month><year>2020</year></pub-date><volume>7</volume><issue>3</issue><fpage>54</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Флоринский Д.Б., Жарков П.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Флоринский Д.Б., Жарков П.А.</copyright-holder><copyright-holder xml:lang="en">Florinskiy D.B., Zharkov P.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nodgo.org/jour/article/view/625">https://journal.nodgo.org/jour/article/view/625</self-uri><abstract><p>Редкие коагулопатии включают в себя наследственные дефициты фибриногена, факторов (F) II, FV, FVII, FX, FXI, FXII и FV + FVIII, а также комбинированный дефицит витамина К-зависимых факторов. Какие-то из данных дефицитов являются более изученными в связи с большим числом пациентов, какие-то дефициты остаются крайне редкими, поэтому на данном этапе для них представляется достаточно сложной проблемой выработка универсального подхода к терапии и профилактике. Задачей данного обзора было оценить частоту, клиническую картину, генетическую основу, возможности и сложности диагностики данных дефицитов.</p></abstract><trans-abstract xml:lang="en"><p>Rare bleeding disorders include inherited deficiencies of fibrinogen, factors (F) II, FV, FVII, FX, FXI, FXII, and FV + FVIII, as well as a multiple deficiency of vitamin K-dependent coagulation factors. Some of these deficiencies are more studied, due to the large number of patients, some are extremely rare, so at this stage it is quite difficult for them to develop a universal approach to therapy and prophylactic treatment. The purpose of this review was to evaluate the frequency, clinical manifestations, genetic basis, possibilities and difficulties of diagnosis for these deficiencies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>редкие коагулопатии</kwd><kwd>FXII</kwd><kwd>концентраты факторов</kwd><kwd>криопреципитат</kwd><kwd>фибриноген</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rare bleeding disorders</kwd><kwd>FXII</kwd><kwd>factor concentrates</kwd><kwd>cryoprecipitate</kwd><kwd>fibrinogen</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mannucci P.M., Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243–52. PMID: 15138162.</mixed-citation><mixed-citation xml:lang="en">Mannucci P.M., Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243–52. PMID: 15138162.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Palla R., Peyvandi F., Shapiro A.D. Rare bleeding disorders: diagnosis and treatment. Blood 2015;125(13):2052‒61. PMID: 25712993.</mixed-citation><mixed-citation xml:lang="en">Palla R., Peyvandi F., Shapiro A.D. Rare bleeding disorders: diagnosis and treatment. Blood 2015;125(13):2052‒61. PMID: 25712993.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">de Moerloose P., Casini A., Neerman-Arbez M. Congenital ﬁbrinogen disorders: an update. Semin Thromb Hemost 2013;39:585–95. PMID: 23852822.</mixed-citation><mixed-citation xml:lang="en">de Moerloose P., Casini A., Neerman-Arbez M. Congenital ﬁbrinogen disorders: an update. Semin Thromb Hemost 2013;39:585–95. PMID: 23852822.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lak M., Keihani M., Elahi F., Peyvandi F., Mannucci P.M. Bleeding and thrombosis in 55 patients with inherited aﬁbrinogenaemia. Br J Haematol 1999;107(1):204–6. PMID: 10520042.</mixed-citation><mixed-citation xml:lang="en">Lak M., Keihani M., Elahi F., Peyvandi F., Mannucci P.M. Bleeding and thrombosis in 55 patients with inherited aﬁbrinogenaemia. Br J Haematol 1999;107(1):204–6. PMID: 10520042.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mackie I.J., Kitchen S., Machin S.J., Lowe G.D. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on Fibrinogen Assays. Br J Haematol 2003;121(3):396‒404. PMID: 12716361.</mixed-citation><mixed-citation xml:lang="en">Mackie I.J., Kitchen S., Machin S.J., Lowe G.D. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on Fibrinogen Assays. Br J Haematol 2003;121(3):396‒404. PMID: 12716361.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lancellotti S., De Cristofaro R. Congenital prothrombin deﬁciency. Semin Thromb Hemost 2009;35(4):367‒81. PMID: 19598065.</mixed-citation><mixed-citation xml:lang="en">Lancellotti S., De Cristofaro R. Congenital prothrombin deﬁciency. Semin Thromb Hemost 2009;35(4):367‒81. PMID: 19598065.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tabibian S., Shiravand Y., Shams M., Safa M., Gholami M.S., Heydari F., Ahmadi A., Rashidpanah J., Dorgalaleh A. A comprehensive overview of coagulation factor V and congenital factor V deﬁciency. Semin Thromb Hemost 2019;45(5):523‒43. PMID: 31121608.</mixed-citation><mixed-citation xml:lang="en">Tabibian S., Shiravand Y., Shams M., Safa M., Gholami M.S., Heydari F., Ahmadi A., Rashidpanah J., Dorgalaleh A. A comprehensive overview of coagulation factor V and congenital factor V deﬁciency. Semin Thromb Hemost 2019;45(5):523‒43. PMID: 31121608.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mariani G., Bernardi F. Factor VII deﬁciency. Semin Thromb Hemost 2009;35(4):400‒6. PMID: 20391303.</mixed-citation><mixed-citation xml:lang="en">Mariani G., Bernardi F. Factor VII deﬁciency. Semin Thromb Hemost 2009;35(4):400‒6. PMID: 20391303.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Girolami A., Berti de Marinis G., Bertozzi I., Peroni E., Tasinato V., Lombardi A.M. Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deﬁciency. Eur J Haematol 2013;91(2):152‒6. PMID: 23621110.</mixed-citation><mixed-citation xml:lang="en">Girolami A., Berti de Marinis G., Bertozzi I., Peroni E., Tasinato V., Lombardi A.M. Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deﬁciency. Eur J Haematol 2013;91(2):152‒6. PMID: 23621110.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wojciechowski V.V., Calina D., Tsarouhas K. A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective. Daru 2017;25(1):10. PMID: 28416008.</mixed-citation><mixed-citation xml:lang="en">Wojciechowski V.V., Calina D., Tsarouhas K. A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective. Daru 2017;25(1):10. PMID: 28416008.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Menegatti M., Peyvandi F. Factor X Deﬁciency. Semin Thromb Hemost 2009;35(4):407‒15. PMID: 19598069.</mixed-citation><mixed-citation xml:lang="en">Menegatti M., Peyvandi F. Factor X Deﬁciency. Semin Thromb Hemost 2009;35(4):407‒15. PMID: 19598069.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Duga S., Salomon O. Factor XI deﬁciency. Semin Thromb Hemost 2009;35(4):416‒25. PMID: 19598070.</mixed-citation><mixed-citation xml:lang="en">Duga S., Salomon O. Factor XI deﬁciency. Semin Thromb Hemost 2009;35(4):416‒25. PMID: 19598070.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dorgalaleh A., Rashidpanah J. Blood coagulation factor XIII and factor XIII deﬁciency. Blood Rev 2016;30(6):461‒75. PMID: 27344554.</mixed-citation><mixed-citation xml:lang="en">Dorgalaleh A., Rashidpanah J. Blood coagulation factor XIII and factor XIII deﬁciency. Blood Rev 2016;30(6):461‒75. PMID: 27344554.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Inbal A., Muszbek L. Coagulation factor deﬁciencies and pregnancy loss. Semin Thromb Hemost 2003;29(2):171–4. PMID: 12709920.</mixed-citation><mixed-citation xml:lang="en">Inbal A., Muszbek L. Coagulation factor deﬁciencies and pregnancy loss. Semin Thromb Hemost 2003;29(2):171–4. PMID: 12709920.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kohler H., Ichinose A., Seitz R., Ariens R., Muszbek L. Diagnosis and classiﬁcation of factor XIII deﬁciencies. J Thromb Haemost 2011;9(7):1404–6. PMID: 22946956.</mixed-citation><mixed-citation xml:lang="en">Kohler H., Ichinose A., Seitz R., Ariens R., Muszbek L. Diagnosis and classiﬁcation of factor XIII deﬁciencies. J Thromb Haemost 2011;9(7):1404–6. PMID: 22946956.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Spreaﬁco M., Peyvandi F. Combined factor V and factor VIII deﬁciency. Semin Thromb Hemost 2009;35(4):390‒9. PMID: 19598067.</mixed-citation><mixed-citation xml:lang="en">Spreaﬁco M., Peyvandi F. Combined factor V and factor VIII deﬁciency. Semin Thromb Hemost 2009;35(4):390‒9. PMID: 19598067.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Brenner B., Kuperman A.A., Watzka M., Oldenburg J. Vitamin K-dependent coagulation factors deﬁciency. Semin Thromb Hemost 2009;35(4):439‒46. PMID: 19598072.</mixed-citation><mixed-citation xml:lang="en">Brenner B., Kuperman A.A., Watzka M., Oldenburg J. Vitamin K-dependent coagulation factors deﬁciency. Semin Thromb Hemost 2009;35(4):439‒46. PMID: 19598072.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Boneh A., Bar-Ziv J. Hereditary deﬁciency of vitamin K dependent coagulation factors with skeletal abnormalities. Am J Med Genet 1996;65:241–3. PMID: 9240751.</mixed-citation><mixed-citation xml:lang="en">Boneh A., Bar-Ziv J. Hereditary deﬁciency of vitamin K dependent coagulation factors with skeletal abnormalities. Am J Med Genet 1996;65:241–3. PMID: 9240751.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ratnoﬀ O.D., Colopy J.E. A familial hemorrhagic trait associated with a deﬁciency of a clot‐promoting fraction of plasma. J Clin Invest 1955;34:602–13. PMID: 14367514.</mixed-citation><mixed-citation xml:lang="en">Ratnoﬀ O.D., Colopy J.E. A familial hemorrhagic trait associated with a deﬁciency of a clot‐promoting fraction of plasma. J Clin Invest 1955;34:602–13. PMID: 14367514.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Stavrou E., Schmaier A.H. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis &amp; thrombosis. Thromb Res 2010;125(3):210–5. PMID: 20022081.</mixed-citation><mixed-citation xml:lang="en">Stavrou E., Schmaier A.H. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis &amp; thrombosis. Thromb Res 2010;125(3):210–5. PMID: 20022081.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Stavrou E.X., Fang C., Bane K.L., Long A.T., Naudin C., Kucukal E., Gandhi A., Brett-Morris A., Mumaw M.M., Izadmehr S., Merkulova A., Reynolds C.C., Alhalabi O., Nayak L., Yu W.-M., Qu C.-K., Meyerson H.J., Dubyak G.R., Gurkan U.A., Nieman M.T., Gupta A.S., Renné T., Schmaier A.H. Factor XII and uPAR upregulate neutrophil functions to inﬂuence wound healing. J Clin Invest 2018;128:944–59. PMID: 29376892.</mixed-citation><mixed-citation xml:lang="en">Stavrou E.X., Fang C., Bane K.L., Long A.T., Naudin C., Kucukal E., Gandhi A., Brett-Morris A., Mumaw M.M., Izadmehr S., Merkulova A., Reynolds C.C., Alhalabi O., Nayak L., Yu W.-M., Qu C.-K., Meyerson H.J., Dubyak G.R., Gurkan U.A., Nieman M.T., Gupta A.S., Renné T., Schmaier A.H. Factor XII and uPAR upregulate neutrophil functions to inﬂuence wound healing. J Clin Invest 2018;128:944–59. PMID: 29376892.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Colman R.W., Schmaier A.H. Contact activation: a vascular biology modulator with anticoagulant, proﬁbrinolytic, antiadhesive, and proinﬂammatory attributes. Blood 1997;90:3819–43. PMID: 9354649.</mixed-citation><mixed-citation xml:lang="en">Colman R.W., Schmaier A.H. Contact activation: a vascular biology modulator with anticoagulant, proﬁbrinolytic, antiadhesive, and proinﬂammatory attributes. Blood 1997;90:3819–43. PMID: 9354649.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lämmle B., Wuillemin W.A., Huber I., Krauskopf M., Zürcher C., Pﬂugshaupt R., Furlan M. Thromboembolism and bleeding tendency in congenital factor XII deﬁciency ‒ a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65(2):117‒21. PMID: 1905067.</mixed-citation><mixed-citation xml:lang="en">Lämmle B., Wuillemin W.A., Huber I., Krauskopf M., Zürcher C., Pﬂugshaupt R., Furlan M. Thromboembolism and bleeding tendency in congenital factor XII deﬁciency ‒ a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65(2):117‒21. PMID: 1905067.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yau J.W., Staﬀord A.R., Liao P., Fredenburgh J.C., Roberts R., Weitz J.I. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood 2011;118(25):6667–74. PMID: 21937693.</mixed-citation><mixed-citation xml:lang="en">Yau J.W., Staﬀord A.R., Liao P., Fredenburgh J.C., Roberts R., Weitz J.I. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood 2011;118(25):6667–74. PMID: 21937693.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Renné T., Pozgajová M., Grüner S., Schuh K., Pauer H.-U., Burfeind P., Gailani D., Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005;202:271–81. PMID: 16009717.</mixed-citation><mixed-citation xml:lang="en">Renné T., Pozgajová M., Grüner S., Schuh K., Pauer H.-U., Burfeind P., Gailani D., Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005;202:271–81. PMID: 16009717.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Merkulov S., Zhang W.-M., Komar A.A., Schmaier A.H., Barnes E., Zhou Y., Lu X., Iwaki T., Castellino F.J., Luo G., McCrae K.R. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 2008;111:1274–81. PMID: 18000168.</mixed-citation><mixed-citation xml:lang="en">Merkulov S., Zhang W.-M., Komar A.A., Schmaier A.H., Barnes E., Zhou Y., Lu X., Iwaki T., Castellino F.J., Luo G., McCrae K.R. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 2008;111:1274–81. PMID: 18000168.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Revenko A.S., Gao D., Crosby J.R., Bhattacharjee G., Zhao C., May C., Gailani D., Monia B.P., MacLeod A.R. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 2011;118(19):5302–11. PMID: 21821705.</mixed-citation><mixed-citation xml:lang="en">Revenko A.S., Gao D., Crosby J.R., Bhattacharjee G., Zhao C., May C., Gailani D., Monia B.P., MacLeod A.R. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 2011;118(19):5302–11. PMID: 21821705.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y., Cai T.Q., Castriota G., Zhou Y., Hoos L., Jochnowitz N., Loewrigkeit C., Cook J.A., Wickham A., Metzger J.M., Ogletree M.L., Seiﬀert D.A., Chen Z. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic beneﬁt. Thromb Haemost 2014;111(4):694‒704. PMID: 24336918.</mixed-citation><mixed-citation xml:lang="en">Xu Y., Cai T.Q., Castriota G., Zhou Y., Hoos L., Jochnowitz N., Loewrigkeit C., Cook J.A., Wickham A., Metzger J.M., Ogletree M.L., Seiﬀert D.A., Chen Z. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic beneﬁt. Thromb Haemost 2014;111(4):694‒704. PMID: 24336918.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Peyvandi F., Palla R., Menegatti M., Siboni S.M., Halimeh S., Faeser B., Pergantou H., Platokouki H., Giangrande P., Peerlinck K., Celkan T., Ozdemir N., Bidlingmaier C., Ingerslev J., Giansily-Blaizot M., Schved J.F., Gilmore R., Gadisseur A., Benedik-Dolničar M., Kitanovski L., Mikovic D., Musallam K.M., Rosendaal F.R.; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10(4):615‒21. PMID: 22321862.</mixed-citation><mixed-citation xml:lang="en">Peyvandi F., Palla R., Menegatti M., Siboni S.M., Halimeh S., Faeser B., Pergantou H., Platokouki H., Giangrande P., Peerlinck K., Celkan T., Ozdemir N., Bidlingmaier C., Ingerslev J., Giansily-Blaizot M., Schved J.F., Gilmore R., Gadisseur A., Benedik-Dolničar M., Kitanovski L., Mikovic D., Musallam K.M., Rosendaal F.R.; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10(4):615‒21. PMID: 22321862.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
